Literature DB >> 25746992

Two Phages, phiIPLA-RODI and phiIPLA-C1C, Lyse Mono- and Dual-Species Staphylococcal Biofilms.

Diana Gutiérrez1, Dieter Vandenheuvel2, Beatriz Martínez1, Ana Rodríguez1, Rob Lavigne2, Pilar García3.   

Abstract

Phage therapy is a promising option for fighting against staphylococcal infections. Two lytic phages, vB_SauM_phiIPLA-RODI (phiIPLA-RODI) and vB_SepM_phiIPLA-C1C (phiIPLA-C1C), belonging to the Myoviridae family and exhibiting wide host ranges, were characterized in this study. The complete genome sequences comprised 142,348 bp and 140,961 bp and contained 213 and 203 open reading frames, respectively. The gene organization was typical of Spounavirinae members, with long direct terminal repeats (LTRs), genes grouped into modules not clearly separated from each other, and several group I introns. In addition, four genes encoding tRNAs were identified in phiIPLA-RODI. Comparative DNA sequence analysis showed high similarities with two phages, GH15 and 676Z, belonging to the Twort-like virus genus (nucleotide identities of >84%); for phiIPLA-C1C, a high similarity with phage phiIBB-SEP1 was observed (identity of 80%). Challenge assays of phages phiIPLA-RODI and phiIPLA-C1C against planktonic staphylococcal cells confirmed their lytic ability, as they were able to remove 5 log units in 8 h. Exposure of biofilms to phages phiIPLA-RODI and phiIPLA-C1C reduced the amount of adhered bacteria to about 2 log units in both monospecies and dual-species biofilms, but phiIPLA-RODI turned out to be as effective as the mixture of both phages. Moreover, the frequencies of bacteriophage-insensitive mutants (BIMs) of Staphylococcus aureus and S. epidermidis with resistance to phiIPLA-RODI and phiIPLA-C1C were low, at 4.05 × 10(-7) ± 2.34 × 10(-9) and 1.1 × 10(-7) ± 2.08 × 10(-9), respectively. Overall, a generally reduced fitness in the absence of phages was observed for BIMs, which showed a restored phage-sensitive phenotype in a few generations. These results confirm that lytic bacteriophages can be efficient biofilm-disrupting agents, supporting their potential as antimicrobials against staphylococcal infections.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25746992      PMCID: PMC4407228          DOI: 10.1128/AEM.03560-14

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  69 in total

1.  A -1 ribosomal frameshift in the transcript that encodes the major head protein of bacteriophage A2 mediates biosynthesis of a second essential component of the capsid.

Authors:  Pilar García; Isabel Rodríguez; Juan E Suárez
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

Review 2.  Bacteriophage resistance mechanisms.

Authors:  Simon J Labrie; Julie E Samson; Sylvain Moineau
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

Review 3.  Genomics of staphylococcal Twort-like phages--potential therapeutics of the post-antibiotic era.

Authors:  Małgorzata Łobocka; Monika S Hejnowicz; Kamil Dąbrowski; Agnieszka Gozdek; Jarosław Kosakowski; Magdalena Witkowska; Magdalena I Ulatowska; Beata Weber-Dąbrowska; Magdalena Kwiatek; Sylwia Parasion; Jan Gawor; Helena Kosowska; Aleksandra Głowacka
Journal:  Adv Virus Res       Date:  2012       Impact factor: 9.937

4.  Comparison of five bacteriophages as models for viral aerosol studies.

Authors:  Nathalie Turgeon; Marie-Josée Toulouse; Bruno Martel; Sylvain Moineau; Caroline Duchaine
Journal:  Appl Environ Microbiol       Date:  2014-05-02       Impact factor: 4.792

5.  Prediction of transcription terminators in bacterial genomes.

Authors:  M D Ermolaeva; H G Khalak; O White; H O Smith; S L Salzberg
Journal:  J Mol Biol       Date:  2000-08-04       Impact factor: 5.469

6.  Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K.

Authors:  N Cerca; R Oliveira; J Azeredo
Journal:  Lett Appl Microbiol       Date:  2007-09       Impact factor: 2.858

7.  Functional genomic analysis of two Staphylococcus aureus phages isolated from the dairy environment.

Authors:  Pilar García; Beatriz Martínez; José María Obeso; Rob Lavigne; Rudi Lurz; Ana Rodríguez
Journal:  Appl Environ Microbiol       Date:  2009-10-16       Impact factor: 4.792

8.  Evaluating efficacy of bacteriophage therapy against Staphylococcus aureus infections using a silkworm larval infection model.

Authors:  Iyo Takemura-Uchiyama; Jumpei Uchiyama; Shin-ichiro Kato; Tetsuyoshi Inoue; Takako Ujihara; Naoya Ohara; Masanori Daibata; Shigenobu Matsuzaki
Journal:  FEMS Microbiol Lett       Date:  2013-08-06       Impact factor: 2.742

9.  Improving the safety of Staphylococcus aureus polyvalent phages by their production on a Staphylococcus xylosus strain.

Authors:  Lynn El Haddad; Nour Ben Abdallah; Pier-Luc Plante; Jeannot Dumaresq; Ramaz Katsarava; Steve Labrie; Jacques Corbeil; Daniel St-Gelais; Sylvain Moineau
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

10.  Staphylococcus epidermidis strains isolated from breast milk of women suffering infectious mastitis: potential virulence traits and resistance to antibiotics.

Authors:  Susana Delgado; Rebeca Arroyo; Esther Jiménez; Maria L Marín; Rosa del Campo; Leonides Fernández; Juan M Rodríguez
Journal:  BMC Microbiol       Date:  2009-05-07       Impact factor: 3.605

View more
  54 in total

Review 1.  Staphylococcal Biofilms.

Authors:  Michael Otto
Journal:  Microbiol Spectr       Date:  2018-08

2.  The Behavior of Staphylococcus aureus Dual-Species Biofilms Treated with Bacteriophage phiIPLA-RODI Depends on the Accompanying Microorganism.

Authors:  Silvia González; Lucía Fernández; Ana Belén Campelo; Diana Gutiérrez; Beatriz Martínez; Ana Rodríguez; Pilar García
Journal:  Appl Environ Microbiol       Date:  2017-01-17       Impact factor: 4.792

3.  Nonconventional Therapeutics against Staphylococcus aureus.

Authors:  Caroline M Grunenwald; Monique R Bennett; Eric P Skaar
Journal:  Microbiol Spectr       Date:  2018-11

4.  Current Research Approaches to Target Biofilm Infections.

Authors:  Erik van Tilburg Bernardes; Shawn Lewenza; Shauna Reckseidler-Zenteno
Journal:  Postdoc J       Date:  2015-06

5.  TSP, a virulent Podovirus, can control the growth of Staphylococcus aureus for 12 h.

Authors:  Rabia Tabassum; Abdul Basit; Iqbal Ahmed Alvi; Muhammad Asif; Shafiq Ur Rehman
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

6.  Correlation of Host Range Expansion of Therapeutic Bacteriophage Sb-1 with Allele State at a Hypervariable Repeat Locus.

Authors:  Kirill V Sergueev; Andrey A Filippov; Jason Farlow; Wanwen Su; Leila Kvachadze; Nana Balarjishvili; Mzia Kutateladze; Mikeljon P Nikolich
Journal:  Appl Environ Microbiol       Date:  2019-10-30       Impact factor: 4.792

7.  Environmental pH is a key modulator of Staphylococcus aureus biofilm development under predation by the virulent phage phiIPLA-RODI.

Authors:  Lucía Fernández; Diana Gutiérrez; Pilar García; Ana Rodríguez
Journal:  ISME J       Date:  2020-09-22       Impact factor: 10.302

8.  The interactions of bacteriophage Ace and Shiga toxin-producing Escherichia coli during biocontrol.

Authors:  Graça Pinto; Scott A Minnich; Carolyn J Hovde; Hugo Oliveira; Hauke Smidt; Carina Almeida; Joana Azeredo
Journal:  FEMS Microbiol Ecol       Date:  2021-08-03       Impact factor: 4.194

9.  High efficacy of a characterized lytic bacteriophage in combination with thyme essential oil against multidrug-resistant Staphylococcus aureus in chicken products.

Authors:  K Abdallah; A Tharwat; R Gharieb
Journal:  Iran J Vet Res       Date:  2021       Impact factor: 1.376

10.  Phenotypic and Genotypic Characterization of Novel Polyvalent Bacteriophages With Potent In Vitro Activity Against an International Collection of Genetically Diverse Staphylococcus aureus.

Authors:  Elliot Whittard; James Redfern; Guoqing Xia; Andrew Millard; Roobinidevi Ragupathy; Sladjana Malic; Mark C Enright
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.